enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Prostate cancer screening - Wikipedia

   en.wikipedia.org/wiki/Prostate_cancer_screening

   The Prostate Health Index (PHI) is a PSA-based blood test for early prostate cancer screening. It may be used to determine when a biopsy is needed. [32] [46] Prostate cancer antigen 3 is a urine test that detects the overexpression of the PCA3 gene, an indicator of prostate cancer. [32] [46] [47] [44]

3. What Your PSA Test Says About Your Prostate - AOL

   www.aol.com/psa-test-says-prostate-110000368.html

   The test measures the amount of PSA, a protein that your prostate makes, in your blood, explains Richard Levin, M.D., a urologist and vice chief of staff of the medical executive committee at HCA ...

4. Charity calls for change to prostate cancer testing guidelines

   www.aol.com/charity-calls-change-prostate-cancer...

   Men at a higher risk of prostate cancer should be given the option to have a test by their GP even if they have no symptoms, a charity has said, as it warned current NHS guidelines are “driving ...

5. Prostate-specific antigen - Wikipedia

   en.wikipedia.org/wiki/Prostate-specific_antigen

   Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), P-30 antigen, is a glycoprotein enzyme encoded in humans by the KLK3 gene.PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland in men and the paraurethral glands in women.

6. Gleason grading system - Wikipedia

   en.wikipedia.org/wiki/Gleason_grading_system

   The Gleason grading system is used to help evaluate the prognosis of men with prostate cancer using samples from a prostate biopsy. Together with other parameters, it is incorporated into a strategy of prostate cancer staging which predicts prognosis and helps guide therapy. A Gleason score is given to prostate cancer based upon its microscopic ...

7. Cancer screening - Wikipedia

   en.wikipedia.org/wiki/Cancer_screening

   Prostate cancer was estimated to be the second leading cause of death by cancer in the US in 2018. [35] There are different methods used in screening for prostate cancer prostate biopsy, prostate-specific antigen testing (PSA), and digital rectal examination (DRE). In the DRE the examiner inserts a finger in the rectum of the patient and ...